Association for Cancer Immunotherapy CIMT
Register of Associations
Amtsgericht Mainz: VR 3783
Prof. Dr. C. Huber
CIMT President (Mainz, Germany)
Prof. Dr. C. Melief
ISA Pharmaceuticals (Leiden, The Netherlands)
Prof. Dr. C. Figdor
St. Radboud University Medical Center (Nijmegen, The Netherlands)
Dr. Özlem Türeci
Cluster for Individualized ImmuneIntervention Ci3 (Mainz, Germany)
Dr. Sebastian Kreiter
TRON-Translational Oncology (Mainz, Germany)
Association for Cancer Immunotherapy (CIMT)/
Immunologische Krebs-Therapie e.V.
Design & Implementation
Conditions of use
The content provided on this page belongs to the Association for Cancer Immunotherapy CIMT and is protected by copyright laws. The use of texts, illustrations and content (i.e. press publications, data collections, photos or similar) from this page is prohibited.
The indicated source is exclusively responsible for the contents of the press report. Association for Cancer Immunotherapy assumes no responsibility for the correctness of the contents published in the “Press Release”, their legality or for any issues relating to copyright.
The CIMT website was conscientiously designed for general information purposes. However, no warranty is given that information supplied by CIMT is complete and without errors.
Therefore, CIMT does not assume any liability for the completeness, correctness and applicability of the transmitted information, and is not responsible for any damages incurred as a consequence of the application of the transmitted information.
© Association for Cancer Immunotherapy CIMT.
All rights reserved.
Explanation about the use of links to other homepages
According to article 5, paragraph 1 of the German Telecommunications Act (TDG) from July 22, 1997, The Association for Cancer Immunotherapy, as the content provider, is responsible subject to general law for the content made available for download. This content is to be differentiated from references (links) to content provided by others.
The Association for Cancer Immunotherapy is only responsible if there is notice of content (i.e. content liable to prosecution) and if it is possible and reasonable to prevent its use (Article 5, paragraph 2 TDG). At the initial reference, the Association for Cancer Immunotherapy has reviewed outside links regarding possible charges of civilian or criminal liability.
In accordance with the TDG, the Association for Cancer Immunotherapy is not obliged to continuously review outside reference that might again justify a charge of liability.
All listed registered trademarks, logos, names and titles are the sole possession of the respective owners.
Disclaimer google analytics